{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04386616: Phase 2 Interventional Completed COVID-19 Pneumonia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04269083: Not Applicable Interventional Unknown status Esophageal Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:gruticibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03251482: Phase 2 Interventional Completed VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03286517: Phase 3 Interventional Completed Reproductive Physiological Phenomena
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00215644: Phase 2 Interventional Completed Esophageal Cancer
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03964233: Phase 1 Interventional Active, not recruiting Neoplasms
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02010099: Phase 2/Phase 3 Interventional Completed Bleeding Hemorrhoids
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03846453: Phase 3 Interventional Completed Dry Eye
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01042379: Phase 2 Interventional Recruiting Breast Neoplasms
(2010)
Source URL:
Class:
PROTEIN
